Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM2ED
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,692
Award facts
- Contract value 100% obligated
- $11,691.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,691.92 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pens on January 12, 2026, with completion targeted for January 13, 2026. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected through open competition for this pharmaceutical supply requirement. The company's extensive federal contracting portfolio demonstrates its capability to fulfill diverse medical supply needs for military and veteran healthcare systems, including specialty medications, branded and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Zepbound, a GLP-1 receptor agonist diabetes and weight management medication, represents the type of specialized pharmaceutical commodity the company routinely delivers through its DLA contract vehicles to support Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM2ED?
SPE2DR26FM2ED was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FM2ED worth?
The government has obligated $11,692 on SPE2DR26FM2ED.
Is contract SPE2DR26FM2ED an order under another contract?
Yes. SPE2DR26FM2ED is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM2ED competed?
The extent of competition for SPE2DR26FM2ED was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award